Bloomberg Law
Feb. 23, 2023, 4:12 PM

FDA, Patent Office Extend Feedback Time on Boosting Drug Access

Riddhi Setty
Riddhi Setty

The public will have an additional two weeks to comment on efforts by the US Food and Drug Administration and US Patent and Trademark Office to make medicine more accessible.

Input will be due 14 days after the agencies publish a notice in Friday’s Federal Register.

Their collaboration seeks to implement President Joe Biden’s July 2021 executive order to promote competition and support increased access to medicines for American families. It was first introduced last November.

Shortly after, the PTO faced criticism from progressive lawmakers Sen. Elizabeth Warren (D-Mass.) and Rep. Pramila Jayapal (D-Wash.), who said the agency hasn’t done ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.